Rubius Therapeutics
RUBY
$0.02198
Share price
7.74%
Change (1 day)
-98.28%
Change (1 year)
Categories
Earnings for Rubius Therapeutics (RUBY)
Earnings in 2022 (TTM): -$0.18 B
According to Rubius Therapeutics 's latest financial reports the company's current earnings (TTM) are -$0.18 B. In 2021 the company made an earning of -$0.2 B a decrease over its 2020 earnings that were of -$0.17 B.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Rubius Therapeutics from 2017 to 2022
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2022 (TTM)  | -$0.18 B | -8.59% |
| 2021 | -$0.2 B | 17.18% |
| 2020 | -$0.17 B | 2.61% |
| 2019 | -$0.17 B | 66.97% |
| 2018 | -$97.9 M | 123.27% |
| 2017 | -$43.85 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | -$0.12 B | -38.34% | 🇺🇸 USA |